CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.06B
1-Year Est. Return 31.81%
This Quarter Est. Return
1 Year Est. Return
+31.81%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.06B
AUM Growth
-$12.1M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
501
New
Increased
Reduced
Closed

Top Buys

1
+$6.59M
2
+$4.62M
3
+$3.73M
4
GLDM icon
SPDR Gold MiniShares Trust
GLDM
+$3.6M
5
TMUS icon
T-Mobile US
TMUS
+$2.35M

Top Sells

1
+$17.4M
2
+$12.2M
3
+$11.5M
4
AMZN icon
Amazon
AMZN
+$8.86M
5
AVGO icon
Broadcom
AVGO
+$8.43M

Sector Composition

1 Technology 38.15%
2 Healthcare 22.68%
3 Communication Services 12.64%
4 Consumer Discretionary 11.62%
5 Consumer Staples 3.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRMD icon
326
CorMedix
CRMD
$886M
$168K 0.02%
13,622
+1,451
LENZ
327
LENZ Therapeutics
LENZ
$927M
$166K 0.02%
5,653
+137
COGT icon
328
Cogent Biosciences
COGT
$2.24B
$164K 0.02%
22,868
+32
SNDX icon
329
Syndax Pharmaceuticals
SNDX
$1.14B
$162K 0.02%
17,282
+161
AVXL icon
330
Anavex Life Sciences
AVXL
$689M
$158K 0.01%
17,147
+85
ZTS icon
331
Zoetis
ZTS
$63.8B
$154K 0.01%
986
QURE icon
332
uniQure
QURE
$4.35B
$153K 0.01%
10,996
-578
ZK icon
333
Zeekr
ZK
$7.44B
$153K 0.01%
6,000
-6,000
XERS icon
334
Xeris Biopharma Holdings
XERS
$1.55B
$150K 0.01%
32,167
+2,264
AVBP icon
335
ArriVent BioPharma
AVBP
$758M
$150K 0.01%
6,871
+112
GLUE icon
336
Monte Rosa Therapeutics
GLUE
$772M
$146K 0.01%
32,354
+20,031
ORIC icon
337
Oric Pharmaceuticals
ORIC
$1.26B
$145K 0.01%
14,278
+31
REPL icon
338
Replimune Group
REPL
$797M
$144K 0.01%
15,483
+35
VIR icon
339
Vir Biotechnology
VIR
$821M
$140K 0.01%
27,765
+256
PHAT icon
340
Phathom Pharmaceuticals
PHAT
$960M
$134K 0.01%
14,022
+307
DAWN icon
341
Day One Biopharmaceuticals
DAWN
$721M
$132K 0.01%
20,358
+28
ANAB icon
342
AnaptysBio
ANAB
$1.01B
$131K 0.01%
5,901
-250
EYPT icon
343
EyePoint Pharmaceuticals
EYPT
$947M
$130K 0.01%
13,821
+131
URGN icon
344
UroGen Pharma
URGN
$915M
$127K 0.01%
9,261
+797
STOK icon
345
Stoke Therapeutics
STOK
$1.72B
$124K 0.01%
10,966
+342
SANA icon
346
Sana Biotechnology
SANA
$1.38B
$124K 0.01%
45,302
+518
TSHA icon
347
Taysha Gene Therapies
TSHA
$1.37B
$121K 0.01%
52,527
+11,407
EOLS icon
348
Evolus
EOLS
$444M
$119K 0.01%
12,950
+249
RLAY icon
349
Relay Therapeutics
RLAY
$1.26B
$119K 0.01%
34,434
+431
ABUS icon
350
Arbutus Biopharma
ABUS
$884M
$119K 0.01%
38,467
+458
12 13
14
15 16